| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication | 
|---|
| C016403 | 2,4-dinitrotoluene | 2,4-dinitrotoluene affects the expression of PROS1 mRNA | affects expression | 21346803 
 | 
| C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene affects the expression of PROS1 mRNA | affects expression | 21346803 
 | 
| C472791 | 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid | 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of PROS1 mRNA | increases expression | 16788091 
 | 
| C430898 | AGN 194204 | AGN 194204 results in increased expression of PROS1 mRNA | increases expression | 16339527 
 | 
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of PROS1 mRNA | affects expression | 16483693 
 | 
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PROS1 mRNA | increases expression | 20382639 
 | 
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased expression of PROS1 mRNA | decreases expression | 15336504 
 | 
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of PROS1 mRNA | affects expression | 17484886 
 | 
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of PROS1 mRNA | decreases expression | 16239168 
 | 
| D003035 | Cobalt | [tungsten carbide binds to Cobalt] which results in decreased expression of PROS1 mRNA | affects binding|decreases expression | 20105288 
 | 
| D003276 | Contraceptives, Oral | Contraceptives, Oral results in decreased expression of PROS1 | decreases expression | 15185533 
 | 
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of PROS1 mRNA | decreases expression | 20106945 
 | 
| D017135 | Desogestrel | Desogestrel affects the expression of PROS1 protein | affects expression | 11442481 
 | 
| D002945 | Cisplatin | PROS1 protein affects the susceptibility to Cisplatin | affects response to substance | 16217747 
 | 
| C023635 | dienogest | [Ethinyl Estradiol co-treated with dienogest] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 15288212 
 | 
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine affects the expression of PROS1 mRNA | affects expression | 16995903 
 | 
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine affects the expression of PROS1 protein | affects expression | 16995903 
 | 
| D004958 | Estradiol | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PROS1 mRNA | affects cotreatment|decreases expression | 19619570 
 | 
| D004958 | Estradiol | Estradiol results in increased expression of PROS1 mRNA | increases expression | 19619570 
 | 
| C454300 | estradiol valerate-dienogest | [Ethinyl Estradiol co-treated with estradiol valerate-dienogest] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 15288212 
 | 
| D004966 | Estrogens, Conjugated (USP) | Estrogens, Conjugated (USP) results in decreased expression of PROS1 protein | decreases expression | 15850603 
 | 
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with dienogest] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 15288212 
 | 
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with estradiol valerate-dienogest] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 15288212 
 | 
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with Gestodene] affects the expression of PROS1 protein | affects cotreatment|affects expression | 11720199 
 | 
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of PROS1 protein | affects cotreatment|decreases activity | 11994571 
 | 
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with Gestodene] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 12618251 16522526
 
 | 
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with Gestodene] results in increased expression of PROS1 | affects cotreatment|increases expression | 15669648 
 | 
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased activity of PROS1 protein | affects cotreatment|decreases activity | 14551147 
 | 
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 12618251 
 | 
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with norgestimate] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 12618251 
 | 
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of PROS1 protein | decreases expression | 17374706 
 | 
| C442659 | ethinyl estradiol-desogestrel combination | ethinyl estradiol-desogestrel combination results in decreased activity of PROS1 protein | decreases activity | 11994571 14551147
 
 | 
| C442659 | ethinyl estradiol-desogestrel combination | ethinyl estradiol-desogestrel combination results in decreased expression of PROS1 protein | decreases expression | 12618251 10928463
 15318540
 
 | 
| C033273 | Gestodene | [Ethinyl Estradiol co-treated with Gestodene] affects the expression of PROS1 protein | affects cotreatment|affects expression | 11720199 
 | 
| C033273 | Gestodene | [Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of PROS1 protein | affects cotreatment|decreases activity | 11994571 
 | 
| C033273 | Gestodene | [Ethinyl Estradiol co-treated with Gestodene] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 12618251 16522526
 
 | 
| C033273 | Gestodene | [Ethinyl Estradiol co-treated with Gestodene] results in increased expression of PROS1 | affects cotreatment|increases expression | 15669648 
 | 
| C017576 | norgestimate | [Ethinyl Estradiol co-treated with norgestimate] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 12618251 
 | 
| D016912 | Levonorgestrel | [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased activity of PROS1 protein | affects cotreatment|decreases activity | 14551147 
 | 
| D016912 | Levonorgestrel | [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of PROS1 protein | affects cotreatment|decreases expression | 12618251 
 | 
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PROS1 mRNA | affects binding|decreases expression|increases activity | 19710929 
 | 
| D020849 | Raloxifene | Raloxifene affects the expression of PROS1 protein | affects expression | 15850603 
 | 
| D020849 | Raloxifene | Raloxifene results in decreased expression of PROS1 protein | decreases expression | 16202731 
 | 
| D013629 | Tamoxifen | Tamoxifen affects the expression of PROS1 protein | affects expression | 15850603 
 | 
| D013749 | Tetrachlorodibenzodioxin | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PROS1 mRNA | affects cotreatment|decreases expression | 19619570 
 | 
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of PROS1 mRNA | decreases expression | 19619570 
 | 
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of PROS1 mRNA | affects binding|decreases expression | 16214954 
 | 
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of PROS1 mRNA | decreases expression | 18796159 
 | 
| C002802 | tungsten carbide | [tungsten carbide binds to Cobalt] which results in decreased expression of PROS1 mRNA | affects binding|decreases expression | 20105288 
 | 
| C002802 | tungsten carbide | tungsten carbide results in decreased expression of PROS1 mRNA | decreases expression | 20105288 
 | 
| D014812 | Vitamin K | Vitamin K affects the carboxylation of and affects the secretion of PROS1 protein | affects carboxylation|affects secretion | 10706868 
 | 
| D014859 | Warfarin | PROS1 gene polymorphism affects the susceptibility to Warfarin | affects response to substance | 19752777 
 | 
| D014859 | Warfarin | PROS1 protein affects the susceptibility to Warfarin | affects response to substance | 19752777 
 | 
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication | 
|---|
| MESH:D000008 | Abdominal Neoplasms |  | Tamoxifen | 4.26 | 14745880 | 
| MESH:D000014 | Abnormalities, Drug-Induced |  | Tetrachlorodibenzodioxin | 2.57 | 15322242	14514962	11752688 | 
| MESH:D000138 | Acidosis |  | Ammonium Chloride | 3.28 | 18287403 | 
| MESH:D000152 | Acne Vulgaris |  | Ethinyl Estradiol | 11.37 | 17505938 | 
| MESH:D000152 | Acne Vulgaris |  | norgestimate | 11.37 | 17505938 | 
| MESH:D058186 | Acute Kidney Injury |  | Cisplatin | 3.71 | 15814532	17670903	12690470 | 
| MESH:D055371 | Acute Lung Injury |  | pirinixic acid | 2.86 | 18653653 | 
| MESH:D000230 | Adenocarcinoma |  | Cisplatin | 9.59 | 17638652	11798837 | 
| MESH:D000230 | Adenocarcinoma |  | Dimethylnitrosamine | 9.59 | 16033868 | 
| MESH:D000230 | Adenocarcinoma |  | Estradiol | 9.59 | 11473722 | 
| MESH:D000230 | Adenocarcinoma |  | Ethinyl Estradiol | 9.59 | 14692618 | 
| MESH:D000236 | Adenoma |  | Dimethylnitrosamine | 3.39 | 19555203 | 
| MESH:D018248 | Adenoma, Liver Cell |  | pirinixic acid | 8.97 | 16434500 | 
| MESH:D018248 | Adenoma, Liver Cell |  | Tetrachlorodibenzodioxin | 8.97 | 16835633 | 
| MESH:D000419 | Albuminuria |  | Raloxifene | 4.33 | 17308373	17451421 | 
| MESH:D000544 | Alzheimer Disease |  | Raloxifene | 2.48 | 15800139 | 
| MESH:D000740 | Anemia |  | Tetrachlorodibenzodioxin | 2.71 | 11748828 | 
| MESH:D001161 | Arteriosclerosis |  | Ethinyl Estradiol | 3.19 | 11256880 | 
| MESH:D001169 | Arthritis, Experimental |  | Ethinyl Estradiol | 2.49 | 15885639 | 
| MESH:D001778 | Blood Coagulation Disorders |  | pirinixic acid | 7.94 | 19483382 | 
| MESH:D001778 | Blood Coagulation Disorders |  | Tetrachlorodibenzodioxin | 7.94 | 12125929 | 
| MESH:D001836 | Body Weight Changes |  | Tetrachlorodibenzodioxin | 3.51 | 15340226 | 
| MESH:D001848 | Bone Diseases, Developmental |  | Tetrachlorodibenzodioxin | 2.59 | 15746008 | 
| MESH:D019046 | Bone Marrow Neoplasms |  | Cisplatin | 4.60 | 14601052 | 
| MESH:D001930 | Brain Injuries |  | Raloxifene | 4.20 | 16580743 | 
| MESH:D001943 | Breast Neoplasms |  | Cisplatin | 2.83 | 18382427	19526202 | 
| MESH:D001943 | Breast Neoplasms |  | Cobalt | 2.83 | 15986119 | 
| MESH:D001943 | Breast Neoplasms |  | Estradiol | 2.83 | 17261762	14630087	19861407	17018787	12948864	16675129	17289903	18497071 | 
| MESH:D001943 | Breast Neoplasms |  | Raloxifene | 2.83 | 15572757	17595753	17893378	17952589	15758505	16837676	17049068	16912660	17440819	17261762	17242785	15775269 | 
| MESH:D001943 | Breast Neoplasms |  | Tamoxifen | 2.83 | 16873071	19011961	19059307	19189212	19487384	17242785	19410462	16202921	15565566	20135344	19288272	18351453	19289846	19155303	20544844	18855134	21138602	19142967	18425577	19084267	17440819	20065188	16273361	19066611	19115204	20005174	15668708	18984771	20390343	19221464	19244106	11161223	20859285	18629630	19103187	19189210	17261762	18815881	21152245	18821012	17049068	18997820	19200415	16818667	17893378 | 
| MESH:D001943 | Breast Neoplasms |  | Tetrachlorodibenzodioxin | 2.83 | 20435547 | 
| MESH:D002181 | Candidiasis, Vulvovaginal |  | Estradiol | 4.18 | 16111702 | 
| MESH:D002252 | Carbon Tetrachloride Poisoning |  | Carbon Tetrachloride | 3.51 | 3786805	15700767	18705752	15721981	16097048	16227642	16011737	15673190	16192424	16124888	16050911	10355542 | 
| MESH:D002277 | Carcinoma |  | Dimethylnitrosamine | 7.63 | 19555203 | 
| MESH:D002277 | Carcinoma |  | Tetrachlorodibenzodioxin | 7.63 | 16835633 | 
| MESH:D018270 | Carcinoma, Ductal, Breast |  | Tamoxifen | 4.23 | 19066611 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | 2,4-dinitrotoluene | 13.34 | 16705839 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | 2,6-dinitrotoluene | 13.34 | 16705839 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Carbon Tetrachloride | 13.34 | 18788625 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Cisplatin | 13.34 | 17982673 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Estradiol | 13.34 | 16924424 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Tamoxifen | 13.34 | 16924424 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Vitamin K | 13.34 | 16328049 | 
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung |  | Cisplatin | 2.94 | 12023789	16685392 | 
| MESH:D002294 | Carcinoma, Squamous Cell |  | Cisplatin | 4.81 | 17066447	18337622	6189445 | 
| MESH:D002294 | Carcinoma, Squamous Cell |  | Dimethylnitrosamine | 4.81 | 16033868 | 
| MESH:D002295 | Carcinoma, Transitional Cell |  | Raloxifene | 8.70 | 17572228 | 
| MESH:D002295 | Carcinoma, Transitional Cell |  | Tamoxifen | 8.70 | 17572228 | 
| MESH:D006332 | Cardiomegaly |  | Tetrachlorodibenzodioxin | 2.21 | 18670907	18850075	16120746 | 
| MESH:D002318 | Cardiovascular Diseases |  | Raloxifene | 3.26 | 15775269 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | 2,6-dinitrotoluene | 14.43 | 6135515 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 14.43 | 20889678 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | Cyclosporine | 14.43 | 12371664 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | Estradiol | 14.43 | 18566989 | 
| MESH:D002543 | Cerebral Hemorrhage |  | Warfarin | 5.58 | 11061249 | 
| MESH:D018281 | Cholangiocarcinoma |  | Tetrachlorodibenzodioxin | 2.93 | 16835633 | 
| MESH:D002779 | Cholestasis |  | Cyclosporine | 17.62 | 19486331 | 
| MESH:D002779 | Cholestasis |  | Ethinyl Estradiol | 17.62 | 16919318	11677210	16105132	17110522	15861022	17681005	17333356 | 
| MESH:D002779 | Cholestasis |  | Levonorgestrel | 17.62 | 15861022 | 
| MESH:D002779 | Cholestasis |  | pirinixic acid | 17.62 | 19176532 | 
| MESH:D002972 | Cleft Palate |  | Tetrachlorodibenzodioxin | 1.99 | 16354765	8697196	12621046	15668235	15340226 | 
| MESH:D003072 | Cognition Disorders |  | Raloxifene | 4.34 | 15800139 | 
| MESH:D015179 | Colorectal Neoplasms |  | Cisplatin | 2.32 | 15273666 | 
| MESH:D000013 | Congenital Abnormalities |  | Tetrachlorodibenzodioxin | 2.83 | 14669216	17141729 | 
| MESH:D023903 | Coronary Restenosis |  | Warfarin | 5.41 | 12872399 | 
| OMIM:122700 | COUMARIN RESISTANCE |  | Warfarin | 5.56 | 20497562	20579077 | 
| MESH:D019465 | Craniofacial Abnormalities |  | Tetrachlorodibenzodioxin | 1.24 | 10048152	15322242	20055451 | 
| MESH:D003490 | Cyanosis |  | 2,4-dinitrotoluene | 9.98 | 18551238 | 
| MESH:D003490 | Cyanosis |  | 2,6-dinitrotoluene | 9.98 | 18551238 | 
| MESH:D003711 | Demyelinating Diseases |  | Tamoxifen | 4.09 | 19031437 | 
| MESH:D003865 | Depressive Disorder, Major |  | Raloxifene | 3.93 | 17474826 | 
| MESH:D003876 | Dermatitis, Atopic |  | pirinixic acid | 2.30 | 18249437 | 
| MESH:D003922 | Diabetes Mellitus, Type 1 |  | Warfarin | 3.97 | 18772604 | 
| MESH:D003924 | Diabetes Mellitus, Type 2 |  | Tetrachlorodibenzodioxin | 1.60 | 17107852 | 
| MESH:D003928 | Diabetic Nephropathies |  | Estradiol | 19.57 | 19279558 | 
| MESH:D003928 | Diabetic Nephropathies |  | Raloxifene | 19.57 | 17451421	17308373	15920148 | 
| MESH:D003928 | Diabetic Nephropathies |  | Tamoxifen | 19.57 | 19279558 | 
| MESH:D003928 | Diabetic Nephropathies |  | Warfarin | 19.57 | 12644472 | 
| MESH:D003875 | Drug Eruptions |  | Warfarin | 5.71 | 14723717 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | 2,4-dinitrotoluene | 11.08 | 18551238	21346803 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | 2,6-dinitrotoluene | 11.08 | 18551238	21346803 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | Carbon Tetrachloride | 11.08 | 19336974	15027814	3732212	21278145	11566570	10915739	7120509	9327722	6884620	2869522	19085960	10092053	6623471	4309450	3786805	17522070	15998439	16227642	16177239	7440962	15968718	7179309 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | Dimethylnitrosamine | 11.08 | 8172417 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | Tetrachlorodibenzodioxin | 11.08 | 20420201 | 
| MESH:D004362 | Drug Toxicity |  | Cisplatin | 7.50 | 15033597	19839026	12231392	12649298 | 
| MESH:D004362 | Drug Toxicity |  | Tetrachlorodibenzodioxin | 7.50 | 11462148 | 
| MESH:D004487 | Edema |  | pirinixic acid | 10.00 | 12083418 | 
| MESH:D004487 | Edema |  | Raloxifene | 10.00 | 15860553 | 
| MESH:D004487 | Edema |  | Tetrachlorodibenzodioxin | 10.00 | 11000095	12711302 | 
| MESH:D004489 | Edema, Cardiac |  | Tetrachlorodibenzodioxin | 3.62 | 15322242	16714409	18230668 | 
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental |  | Ethinyl Estradiol | 13.81 | 12538720 | 
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental |  | Raloxifene | 13.81 | 15845917 | 
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental |  | Tamoxifen | 13.81 | 19031437 | 
| MESH:D016889 | Endometrial Neoplasms |  | Estradiol | 6.79 | 11473722	19148513	18566989 | 
| MESH:D016889 | Endometrial Neoplasms |  | Tamoxifen | 6.79 | 16202921	20544844	19155303	17893378 | 
| MESH:D004715 | Endometriosis |  | Tetrachlorodibenzodioxin | 2.78 | 10568697	9294722 | 
| MESH:D004938 | Esophageal Neoplasms |  | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 6.95 | 20426865 | 
| MESH:D004938 | Esophageal Neoplasms |  | Cisplatin | 6.95 | 15464296	16481741	17638652	15173087	16785472 | 
| MESH:D004938 | Esophageal Neoplasms |  | Dimethylnitrosamine | 6.95 | 17016578 | 
| MESH:D005124 | Eye Abnormalities |  | Tetrachlorodibenzodioxin | 2.81 | 11564622 | 
| MESH:D005234 | Fatty Liver |  | Carbon Tetrachloride | 27.46 | 15959796	12795759	16239168	61145	17595544	12631006	16045604	19224547 | 
| MESH:D005234 | Fatty Liver |  | Cyclosporine | 27.46 | 19224547 | 
| MESH:D005234 | Fatty Liver |  | Ethinyl Estradiol | 27.46 | 15345470 | 
| MESH:D005234 | Fatty Liver |  | pirinixic acid | 27.46 | 20131406	19236843 | 
| MESH:D005234 | Fatty Liver |  | Raloxifene | 27.46 | 17473493 | 
| MESH:D005234 | Fatty Liver |  | Tamoxifen | 27.46 | 19224547	14986274 | 
| MESH:D052776 | Female Urogenital Diseases |  | Tamoxifen | 3.07 | 16709447 | 
| MESH:D005313 | Fetal Death |  | Tetrachlorodibenzodioxin | 3.18 | 11858732 | 
| MESH:D018221 | Fibromatosis, Abdominal |  | Tamoxifen | 4.25 | 14745880 | 
| MESH:D018222 | Fibromatosis, Aggressive |  | Tamoxifen | 3.90 | 19069698 | 
| MESH:D005355 | Fibrosis |  | Carbon Tetrachloride | 13.12 | 18705752 | 
| MESH:D005355 | Fibrosis |  | Cyclosporine | 13.12 | 12639820	12168785 | 
| MESH:D005355 | Fibrosis |  | Tetrachlorodibenzodioxin | 13.12 | 20067830 | 
| MESH:D006471 | Gastrointestinal Hemorrhage |  | Warfarin | 6.43 | 11794436 | 
| MESH:D005776 | Gaucher Disease |  | Warfarin | 5.69 | 12359135 | 
| MESH:D005885 | Gingival Hyperplasia |  | Cyclosporine | 3.94 | 8708960 | 
| MESH:D006058 | Gonadal Disorders |  | Tetrachlorodibenzodioxin | 4.31 | 10696789 | 
| MESH:D006258 | Head and Neck Neoplasms |  | Cisplatin | 3.53 | 15102660	15464296 | 
| MESH:D034381 | Hearing Loss |  | Cisplatin | 4.06 | 19898482 | 
| MESH:D006319 | Hearing Loss, Sensorineural |  | Cisplatin | 4.19 | 15464296 | 
| MESH:D006330 | Heart Defects, Congenital |  | Tetrachlorodibenzodioxin | 2.18 | 10048152	11294989 | 
| MESH:D006331 | Heart Diseases |  | Raloxifene | 3.35 | 11110106 | 
| MESH:D006333 | Heart Failure |  | pirinixic acid | 2.37 | 20558911 | 
| MESH:D006406 | Hematoma |  | Warfarin | 6.43 | 17493413 | 
| MESH:D006457 | Hemoglobinuria, Paroxysmal |  | Cyclosporine | 4.14 | 15720958 | 
| MESH:D006470 | Hemorrhage |  | Tetrachlorodibenzodioxin | 9.67 | 11000095 | 
| MESH:D006470 | Hemorrhage |  | Warfarin | 9.67 | 18429757 | 
| MESH:D006505 | Hepatitis |  | Carbon Tetrachloride | 3.33 | 19900420	19110552 | 
| MESH:D006529 | Hepatomegaly |  | pirinixic acid | 7.35 | 19176532	18467677	19772884	16221962 | 
| MESH:D006529 | Hepatomegaly |  | Tetrachlorodibenzodioxin | 7.35 | 16120746	15340226	12621046 | 
| MESH:D006558 | Herpes Genitalis |  | Estradiol | 4.75 | 15709030 | 
| MESH:D006689 | Hodgkin Disease |  | Cisplatin | 3.37 | 16170182	16200630 | 
| MESH:D019584 | Hot Flashes |  | Estradiol | 3.47 | 17088409 | 
| MESH:D006869 | Hydronephrosis |  | Tetrachlorodibenzodioxin | 3.76 | 15340226	16959395	8697196	16354765	18606429 | 
| MESH:D006932 | Hyperbilirubinemia |  | Carbon Tetrachloride | 4.25 | 16899240 | 
| MESH:D006943 | Hyperglycemia |  | pirinixic acid | 2.94 | 20558911 | 
| MESH:D006973 | Hypertension |  | Cobalt | 11.53 | 17039479 | 
| MESH:D006973 | Hypertension |  | Cyclosporine | 11.53 | 10903974 | 
| MESH:D006973 | Hypertension |  | Raloxifene | 11.53 | 15787275	17577099 | 
| MESH:D006973 | Hypertension |  | Tetrachlorodibenzodioxin | 11.53 | 18670907	18850075 | 
| MESH:D006975 | Hypertension, Portal |  | Carbon Tetrachloride | 3.81 | 15338365 | 
| MESH:D006976 | Hypertension, Pulmonary |  | Warfarin | 4.61 | 12359135 | 
| MESH:D007021 | Hypospadias |  | Ethinyl Estradiol | 3.54 | 16569931	16945680 | 
| MESH:D007247 | Infertility, Female |  | Ethinyl Estradiol | 3.20 | 12013081 | 
| MESH:D007248 | Infertility, Male |  | Ethinyl Estradiol | 2.31 | 17937319 | 
| MESH:D007249 | Inflammation |  | Tamoxifen | 4.41 | 19457130 | 
| MESH:D007249 | Inflammation |  | Tetrachlorodibenzodioxin | 4.41 | 12200463	12878042 | 
| MESH:D007333 | Insulin Resistance |  | Estradiol | 6.59 | 16627594	16393666 | 
| MESH:D007333 | Insulin Resistance |  | pirinixic acid | 6.59 | 16306350 | 
| MESH:D007569 | Jaw Abnormalities |  | Tetrachlorodibenzodioxin | 3.09 | 16580747 | 
| MESH:D007638 | Keratoconjunctivitis Sicca |  | Cyclosporine | 4.16 | 15604871 | 
| MESH:D007673 | Kidney Cortex Necrosis |  | Cisplatin | 4.86 | 15464296 | 
| MESH:D007674 | Kidney Diseases |  | Cisplatin | 9.18 | 15190930	12231392	19839026	18289764	12649298 | 
| MESH:D007674 | Kidney Diseases |  | Cyclosporine | 9.18 | 8314463	18776723	10903974 | 
| MESH:D007674 | Kidney Diseases |  | Estradiol | 9.18 | 15618244 | 
| MESH:D007680 | Kidney Neoplasms |  | 2,4-dinitrotoluene | 20.94 | 16705839 | 
| MESH:D007680 | Kidney Neoplasms |  | 2,6-dinitrotoluene | 20.94 | 16705839 | 
| MESH:D007680 | Kidney Neoplasms |  | Cyclosporine | 20.94 | 12371664 | 
| MESH:D007680 | Kidney Neoplasms |  | Estradiol | 20.94 | 15610895 | 
| MESH:D007680 | Kidney Neoplasms |  | Tamoxifen | 20.94 | 18625569 | 
| MESH:D007683 | Kidney Tubular Necrosis, Acute |  | Cisplatin | 4.51 | 11231351 | 
| MESH:D007889 | Leiomyoma |  | Raloxifene | 4.24 | 16973256 | 
| MESH:D008064 | Lipidoses |  | Tamoxifen | 2.96 | 15342952	17567588 | 
| MESH:D054068 | Livedo Reticularis |  | Warfarin | 6.43 | 18280355 | 
| MESH:D008103 | Liver Cirrhosis |  | Carbon Tetrachloride | 2.66 | 11408273	17174718	16943688	16221502	17157831	17334410	21278145	16239168	11903743 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Carbon Tetrachloride | 8.24 | 14724832	17805973	18263696	15818738	18317297	18279442	18166357	14748882	12586293	17761835	12632512	17557913	15370692	18429990	12649538	12445421	12389079	17640975	15931870	12898905	15123356	18156304	15959796	18472332	20821823	15673190	15925388	18418968	18395095	15338365	12741479	17714472	12609069	10355542	18472094	18251166	18705752	12666154	17922224	17823541	12958196	17721639	15057751	15730626	18420326	18395914	15893842	18210741	11481614	12632514	17481882	16015684	16136751	14716496	17766677	16248980	17900296	12667390	17698563	12546737	14512876	12445418	14620537	18412020	18006644	17708605	18187930	17525996	14716833	18205269	16097048	15876570	17565644	18277467	17631135	18376398	16011737	16027843	16116963	13678700	17869086	18054572	15996030	18339082	16033810	16192424	15052691	15650968	15362042	17976157	17944888	16638106	18481824 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Dimethylnitrosamine | 8.24 | 15577212	16603200	17432682	15591649	15864749	18567088	15086199	14726149	15492853	15339415	15067225	12918455	17666798	15161499	17719030	15369754	17465448	14643895	16042886	15744066	15942678	15571005	16169303	16570917	15763062	17203207	17196135	12925901	18210741	15842777	17036385	17640959	18364076	15733078	14659978	18629640	16544323	17724770	15298665	15504291	15479170	15723089	14709902	14568256	17198567	16009107	17881167	16270385	15099470	15798949	17348192	15383259	18672772	17534399	18095165	17201889	16627068	18239293	18237412	18637143	15138612	18371158	15081153	15366600	15793283 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Estradiol | 8.24 | 14716833	14659978 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | pirinixic acid | 8.24 | 15474484 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Tamoxifen | 8.24 | 18564211 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Tetrachlorodibenzodioxin | 8.24 | 12878042 | 
| MESH:D008107 | Liver Diseases |  | Carbon Tetrachloride | 2.02 | 16246199	16964402	15720792	15830285	17285989 | 
| MESH:D017093 | Liver Failure |  | Carbon Tetrachloride | 3.89 | 15123358 | 
| MESH:D017114 | Liver Failure, Acute |  | Carbon Tetrachloride | 9.04 | 16899240	14706259 | 
| MESH:D017114 | Liver Failure, Acute |  | Dimethylnitrosamine | 9.04 | 17457977 | 
| MESH:D008113 | Liver Neoplasms |  | 2,6-dinitrotoluene | 16.56 | 7678174 | 
| MESH:D008113 | Liver Neoplasms |  | Carbon Tetrachloride | 16.56 | 19294768 | 
| MESH:D008113 | Liver Neoplasms |  | Dimethylnitrosamine | 16.56 | 15890375	3113478 | 
| MESH:D008113 | Liver Neoplasms |  | pirinixic acid | 16.56 | 15890375	20007298	16377806 | 
| MESH:D008113 | Liver Neoplasms |  | Tamoxifen | 16.56 | 16684651 | 
| MESH:D008113 | Liver Neoplasms |  | Tetrachlorodibenzodioxin | 16.56 | 16984957 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | 2,6-dinitrotoluene | 12.71 | 2876784	2876786	6135515 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | Carbon Tetrachloride | 12.71 | 15583823	12014681 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | Dimethylnitrosamine | 12.71 | 6150874	1848544	15603536 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | Tetrachlorodibenzodioxin | 12.71 | 12151625 | 
| MESH:D008173 | Lung Diseases, Obstructive |  | Cobalt | 5.59 | 6434250 | 
| MESH:D008175 | Lung Neoplasms |  | Cisplatin | 4.60 | 17225452	6189445	11798837 | 
| MESH:D008175 | Lung Neoplasms |  | Dimethylnitrosamine | 4.60 | 16061637	19555203	11884234 | 
| MESH:D008175 | Lung Neoplasms |  | Tamoxifen | 4.60 | 18625569 | 
| MESH:D008175 | Lung Neoplasms |  | Tetrachlorodibenzodioxin | 4.60 | 19555203	11884234 | 
| MESH:D015674 | Mammary Neoplasms, Animal |  | Tamoxifen | 3.48 | 19428831 | 
| MESH:D008325 | Mammary Neoplasms, Experimental |  | Estradiol | 5.38 | 16891317	11807958	11408345	17203775 | 
| MESH:D008325 | Mammary Neoplasms, Experimental |  | Tamoxifen | 5.38 | 19196723	11731420	16827153	19196722	14580682 | 
| MESH:D020149 | Manganese Poisoning |  | Estradiol | 11.70 | 19453300 | 
| MESH:D020149 | Manganese Poisoning |  | Tamoxifen | 11.70 | 19453300 | 
| MESH:D008545 | Melanoma |  | Cisplatin | 3.31 | 12883367	16248763	15577323	17761969	18332650	17023156	12393984	16809738	18176117	12374674	11135225	16432458	18505091 | 
| MESH:D008545 | Melanoma |  | Tamoxifen | 3.31 | 19393235	12393984 | 
| MESH:D018328 | Melanoma, Amelanotic |  | Cisplatin | 10.58 | 15990972 | 
| MESH:D018328 | Melanoma, Amelanotic |  | Tamoxifen | 10.58 | 15990972 | 
| MESH:D008654 | Mesothelioma |  | Cisplatin | 3.13 | 17638057 | 
| MESH:D008664 | Metal Metabolism, Inborn Errors |  | Cyclosporine | 4.50 | 16801185 | 
| MESH:D018200 | Mixed Tumor, Mullerian |  | Raloxifene | 5.27 | 15863610 | 
| MESH:D009101 | Multiple Myeloma |  | Raloxifene | 3.24 | 16497877 | 
| MESH:D009135 | Muscular Diseases |  | pirinixic acid | 3.23 | 16239165 | 
| MESH:D009203 | Myocardial Infarction |  | Contraceptives, Oral | 6.13 | 11752354 | 
| MESH:D009203 | Myocardial Infarction |  | pirinixic acid | 6.13 | 19151258 | 
| MESH:D017202 | Myocardial Ischemia |  | Tetrachlorodibenzodioxin | 2.80 | 12213967 | 
| MESH:D015428 | Myocardial Reperfusion Injury |  | Estradiol | 7.55 | 16810080 | 
| MESH:D015428 | Myocardial Reperfusion Injury |  | pirinixic acid | 7.55 | 16411023 | 
| MESH:D009232 | Myxoma |  | Raloxifene | 5.27 | 16343187 | 
| MESH:D009336 | Necrosis |  | 2,4-dinitrotoluene | 16.27 | 18551238 | 
| MESH:D009336 | Necrosis |  | 2,6-dinitrotoluene | 16.27 | 18551238	7678174 | 
| MESH:D009336 | Necrosis |  | Warfarin | 16.27 | 14723717 | 
| MESH:D009362 | Neoplasm Metastasis |  | Tamoxifen | 2.44 | 19393235 | 
| MESH:D009364 | Neoplasm Recurrence, Local |  | Tamoxifen | 2.42 | 19410462 | 
| MESH:D009369 | Neoplasms |  | Cisplatin | 4.65 | 16773208 | 
| MESH:D009369 | Neoplasms |  | pirinixic acid | 4.65 | 17405874 | 
| MESH:D009376 | Neoplasms, Hormone-Dependent |  | Tamoxifen | 3.72 | 19200415	19196722	19189210 | 
| MESH:D009389 | Neovascularization, Pathologic |  | Estradiol | 3.45 | 17289903 | 
| MESH:D009395 | Nephritis, Interstitial |  | Cisplatin | 4.21 | 15464296 | 
| MESH:D009402 | Nephrosis, Lipoid |  | Cyclosporine | 4.16 | 17954296 | 
| MESH:D009404 | Nephrotic Syndrome |  | Cyclosporine | 3.05 | 19348381	18481113 | 
| MESH:D009421 | Nervous System Malformations |  | Estradiol | 8.58 | 11399458	16427766 | 
| MESH:D009421 | Nervous System Malformations |  | Tetrachlorodibenzodioxin | 8.58 | 14600291 | 
| MESH:D009447 | Neuroblastoma |  | Cisplatin | 3.31 | 8761367 | 
| MESH:D017599 | Neuroectodermal Tumors |  | Cisplatin | 4.42 | 8761367 | 
| MESH:D009765 | Obesity |  | pirinixic acid | 1.75 | 20558911 | 
| MESH:D009784 | Occupational Diseases |  | 2,4-dinitrotoluene | 8.08 | 16049721	12819281 | 
| MESH:D009784 | Occupational Diseases |  | 2,6-dinitrotoluene | 8.08 | 16049721 | 
| MESH:D010024 | Osteoporosis |  | Levonorgestrel | 7.28 | 12665316 | 
| MESH:D010024 | Osteoporosis |  | Raloxifene | 7.28 | 15775268	17882678	19059307 | 
| MESH:D015663 | Osteoporosis, Postmenopausal |  | Raloxifene | 3.97 | 17823083	15579764	17893378	15758505 | 
| MESH:D010051 | Ovarian Neoplasms |  | Cisplatin | 4.70 | 15464296	6897625	17225452	19769630 | 
| MESH:D010051 | Ovarian Neoplasms |  | Estradiol | 4.70 | 19401270 | 
| MESH:D010190 | Pancreatic Neoplasms |  | Cisplatin | 2.90 | 19003803 | 
| MESH:D016584 | Panic Disorder |  | Ethinyl Estradiol | 3.43 | 11578682 | 
| MESH:D010382 | Peliosis Hepatis |  | Tetrachlorodibenzodioxin | 3.96 | 12520081 | 
| MESH:D010523 | Peripheral Nervous System Diseases |  | Cisplatin | 4.04 | 15464296 | 
| MESH:D010997 | Pleural Neoplasms |  | Cisplatin | 5.06 | 17638057 | 
| MESH:D011085 | Polycystic Ovary Syndrome |  | ethinyl estradiol-desogestrel combination | 5.35 | 17105841 | 
| MESH:D017119 | Porphyria Cutanea Tarda |  | Tetrachlorodibenzodioxin | 3.29 | 18163543 | 
| MESH:D011230 | Precancerous Conditions |  | Cyclosporine | 2.99 | 12371664 | 
| MESH:D011297 | Prenatal Exposure Delayed Effects |  | Tetrachlorodibenzodioxin | 2.91 | 11399792	11896295	11222880	11118676 | 
| MESH:D019048 | Prostatic Intraepithelial Neoplasia |  | Estradiol | 3.63 | 20887781 | 
| MESH:D011471 | Prostatic Neoplasms |  | AGN 194204 | 2.18 | 16000583 | 
| MESH:D011471 | Prostatic Neoplasms |  | Estradiol | 2.18 | 16740699 | 
| MESH:D011471 | Prostatic Neoplasms |  | Raloxifene | 2.18 | 15731164	16536755	16220300 | 
| MESH:D011471 | Prostatic Neoplasms |  | Tamoxifen | 2.18 | 15067354 | 
| MESH:D020151 | Protein C Deficiency |  | Warfarin | 6.07 | 18376272 | 
| MESH:D011537 | Pruritus |  | Ethinyl Estradiol | 9.07 | 16919318	15861022 | 
| MESH:D011537 | Pruritus |  | Levonorgestrel | 9.07 | 15861022 | 
| MESH:D011565 | Psoriasis |  | Cyclosporine | 2.13 | 16882103 | 
| MESH:D011655 | Pulmonary Embolism |  | Warfarin | 6.07 | 19300499 | 
| MESH:D011658 | Pulmonary Fibrosis |  | Cobalt | 3.89 | 6434250 | 
| MESH:D011693 | Purpura |  | Raloxifene | 5.27 | 15770314 | 
| MESH:D051437 | Renal Insufficiency |  | Cisplatin | 4.13 | 15464296 | 
| MESH:D015427 | Reperfusion Injury |  | pirinixic acid | 2.25 | 19058328 | 
| MESH:D015619 | Respiratory System Abnormalities |  | Tetrachlorodibenzodioxin | 3.57 | 18990726 | 
| MESH:D012512 | Sarcoma, Ewing's |  | Cisplatin | 4.16 | 14601052 | 
| MESH:D012640 | Seizures |  | 2,4-dinitrotoluene | 5.25 | 18551238 | 
| MESH:D012640 | Seizures |  | 2,6-dinitrotoluene | 5.25 | 18551238 | 
| MESH:D012851 | Sinus Thrombosis, Intracranial |  | Warfarin | 5.59 | 12269725 | 
| MESH:D012878 | Skin Neoplasms |  | tert-Butylhydroperoxide | 5.15 | 8532709 | 
| MESH:D012878 | Skin Neoplasms |  | Tetrachlorodibenzodioxin | 5.15 | 16192470 | 
| MESH:D055752 | Small Cell Lung Carcinoma |  | Cisplatin | 5.06 | 15464296 | 
| MESH:D013088 | Spermatocele |  | Ethinyl Estradiol | 10.61 | 16709447 | 
| MESH:D013088 | Spermatocele |  | Tamoxifen | 10.61 | 16709447 | 
| MESH:D013119 | Spinal Cord Injuries |  | Tamoxifen | 3.76 | 19457130 | 
| MESH:D013158 | Splenic Diseases |  | Dimethylnitrosamine | 4.99 | 12587719 | 
| MESH:D013274 | Stomach Neoplasms |  | Cisplatin | 2.80 | 18396642	15958060	17522103 | 
| MESH:D013274 | Stomach Neoplasms |  | Dimethylnitrosamine | 2.80 | 16033868 | 
| MESH:D020521 | Stroke |  | Raloxifene | 8.52 | 16837676 | 
| MESH:D020521 | Stroke |  | Warfarin | 8.52 | 19300499 | 
| MESH:D013736 | Testicular Neoplasms |  | Cisplatin | 4.37 | 17225452	15464296 | 
| MESH:D013923 | Thromboembolism |  | Warfarin | 5.88 | 16960144	18698879 | 
| MESH:D019851 | Thrombophilia |  | Ethinyl Estradiol | 23.97 | 11994571 | 
| MESH:D019851 | Thrombophilia |  | ethinyl estradiol-desogestrel combination | 23.97 | 11994571 | 
| MESH:D019851 | Thrombophilia |  | Gestodene | 23.97 | 11994571 | 
| MESH:D019851 | Thrombophilia |  | Warfarin | 23.97 | 17493413 | 
| OMIM:612336 | THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT | marker/mechanism |  |  |  | 
| MESH:D013927 | Thrombosis |  | Ethinyl Estradiol | 14.21 | 15669648 | 
| MESH:D013927 | Thrombosis |  | Gestodene | 14.21 | 15669648 | 
| MESH:D013927 | Thrombosis |  | Warfarin | 14.21 | 19300499	11307788	17245631	17672075	11518727	15720958 | 
| MESH:D013959 | Thyroid Diseases |  | Tetrachlorodibenzodioxin | 3.62 | 12697716 | 
| MESH:D013978 | Tibial Fractures |  | Estradiol | 12.76 | 19048282 | 
| MESH:D013978 | Tibial Fractures |  | Raloxifene | 12.76 | 19048282 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | 2,4-dinitrotoluene | 14.62 | 16049721 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | 2,6-dinitrotoluene | 14.62 | 16049721 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | Cisplatin | 14.62 | 12973940	15464296	17225452 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | Raloxifene | 14.62 | 17572228 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | Tamoxifen | 14.62 | 16712894	17572228	8653321 | 
| MESH:D014571 | Urologic Neoplasms |  | 2,4-dinitrotoluene | 11.05 | 10091137 | 
| MESH:D014571 | Urologic Neoplasms |  | 2,6-dinitrotoluene | 11.05 | 10091137 | 
| MESH:D002583 | Uterine Cervical Neoplasms |  | Cisplatin | 3.97 | 16803524 | 
| MESH:D014594 | Uterine Neoplasms |  | Ethinyl Estradiol | 3.03 | 14692618 | 
| MESH:D014605 | Uveitis |  | Cyclosporine | 3.70 | 1336536 | 
| MESH:D014625 | Vaginal Neoplasms |  | Cisplatin | 4.34 | 15577323 | 
| MESH:D054079 | Vascular Malformations |  | Tetrachlorodibenzodioxin | 4.31 | 12125929 | 
| MESH:D014657 | Vasculitis |  | Warfarin | 5.59 | 20337814 | 
| MESH:D054556 | Venous Thromboembolism |  | Raloxifene | 13.38 | 16837676 | 
| MESH:D054556 | Venous Thromboembolism |  | Warfarin | 13.38 | 18776969 | 
| MESH:D020246 | Venous Thrombosis |  | Ethinyl Estradiol | 23.27 | 15869587	14671159 | 
| MESH:D020246 | Venous Thrombosis |  | ethinyl estradiol-desogestrel combination | 23.27 | 15869587 | 
| MESH:D020246 | Venous Thrombosis |  | Levonorgestrel | 23.27 | 15869587 | 
| MESH:D020246 | Venous Thrombosis |  | Warfarin | 23.27 | 14723717	15733061 | 
| MESH:D014839 | Vomiting |  | Cisplatin | 4.43 | 11897121 | 
| MESH:D014846 | Vulvar Neoplasms |  | Raloxifene | 5.27 | 16343187 | 
| MESH:D019282 | Wasting Syndrome |  | Tetrachlorodibenzodioxin | 3.96 | 15886252 | 
| MESH:D014985 | Xerophthalmia |  | Cyclosporine | 4.16 | 17120751 |